Minister sets sight on reviving Pankshin, Mambila training camps

first_imgRelatedPosts Military arrests leader, 10 suspected members of a notorious cult group in Jos Unknown persons rip open tummy of 18-month-old in Plateau COVID-19: Plateau research team develops herbal cure The Minister of Youth and Sports Development, Sunday Dare, has directed coaches of long distance races to come up with proposals for renovating the training camps in Pankshin, Plateau State and Mambila, Taraba State to acceptable standards.The Minister, who gave the directive at a virtual meeting with the coaches, the private sector and other stakeholders, also tasked them to initiate the revival of long-distance races. The coaches were also mandated to scout for talents, camp current runners and develop training programmes.They are also to audit the training camps in Mambila and Pankshin to ascertain the extent of renovation needed to bring it up to the desired standard.Dare said: “Following from this meeting, you will put forward a proposal as a team.“That proposal should contain what is needed to bring back the two camps.“I am sure we can conduct an audit. “I am sure some of you know what is needed to bring back Pankshin and Mambila.“Once we see that plan, we can now slice that plan up into two or three stages: what is needed in the short run to activate it quickly to start developing these talents, with the Olympics in view.“In that proposal, we need to also have your idea about the coaches, we need to have your idea about the training templates, as much as possible, so that proposal should determine and put forward what is needed.“You are the expert in this area, and I am sure that you can give us a proposal that is tight but also allows us to do something in the short term and then go ahead to do the medium term and then the long term.“The resources we have are not unlimited, they are limited. “But the ministry will leverage on what it can get and as we prepare the 2021 budget, I will make sure that long distance gets a very close attention.”In what is the first consultations in this direction, Prof. Ezra Gunen, Tony Osheku, Stephen Nuhu and Timon Gunen, Nigeria’s 5,000m record holder as well as Directors of the Sports Ministry joined the meeting to provide insights into long distance races and how best to improve Nigeria’s ranking.Tags: Long Distance RacingMambila Training CampMinister Sunday DarePankshin Training CampPlateau StateTaraba Statelast_img read more

Guanacaste Having it all in Playa Conchal

center_img I stayed in a Royal Beach Junior Suite, which stood out for its multi-level marble floors and prime location across from the Abalone Sports Bar. Never having stayed at an all-inclusive before, I was overwhelmed by the idea of unlimited drinks over the course of three days (don’t ask what went down on day one, I just couldn’t tell you). Pacing oneself is key, obviously, as is continually feasting at the seven restaurants scattered throughout the property.It’s also important to reserve dinner early, as not all the restaurants are created equal, and the most popular – the Italian, the Mediterranean and the French – sometimes fill up. The lobster at Mediterra was small and underwhelming (as you might expect at an all-inclusive), but the beef Carpaccio at Faisanela was so good that I ordered it again for dessert. For breakfast and lunch, you cannot go wrong with Mitra, an open-air international buffet that has everything from ceviche to steak to a personal pasta chef.At some point – a point will be different for every guest – yet another free mojito or meal will begin to deliver diminishing returns. This is when it’s time for an activity (proof you went somewhere!), be ocean kayaking, a round of golf, a massage at the spa, a hike around the active Rincón de la Vieja Volcano, or a snorkel trip at sea, where giant rays, puffer fish and turtles can be spotted. The guys at the activity counter on the resort property will hook you up with pricy but high-quality tours, and the less-official salesmen on the beach are said to offer reasonably good, slightly more affordable iterations.Once you’ve gotten a decent sunburn, eaten yourself immobile and drank yourself incoherent, you are in perfect condition to plunk down in front of the stage and watch the attractive, agile entertainers busting moves in flashy costumes while lip synching pop songs such as Ricky Martin’s “Livin’ la Vida Loca.” There are also some Cirque du Soleil-style performances, including a stellar silk trapeze act. The show each night ends just like “Dirty Dancing,” with the performers cajoling audience members into joining the dance party, and eventually the whole place is up, celebrating the right to have and do whatever they want.Going thereRates range from $338-$1,148 a night. Sansa and Nature Air flights land you at the Tamarindo or Liberia airports, from which a shuttle will transport you for $25 and $90, respectively.For more info, call 2654-3500 or visit Facebook Commentslast_img read more

Clinical trial Promising drug slows brain shrinkage in progressive MS patients

first_imgReviewed by James Ives, M.Psych. (Editor)Aug 30 2018A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease.The definitive results of the phase 2 trial – published in the New England Journal of Medicine – showed that the drug ibudilast decreased progression of brain atrophy in progressive MS patients by 48 percent versus placebo. The two-year SPRINT-MS study was conducted at 28 sites with 255 patients.”These findings are significant for patients with progressive MS,” said Robert Fox, M.D., the study’s principal investigator and vice-chair for research in Cleveland Clinic’s Neurological Institute. “Our hope is that the benefit of ibudilast in slowing brain shrinkage will also translate to decreased progression of associated physical disabilities in a future phase 3 trial.”Progressive MS is associated with gradual worsening of symptoms and increasing disability. It commonly follows relapsing-remitting MS, for which there are more than a dozen approved treatments. However, none of these therapies has consistently demonstrated efficacy in slowing disability progression in patients with progressive MS, particularly those without evidence for active inflammation.Ibudilast, an oral drug with activity on several biologic pathways with potential relevance to progressive MS, was approved in Japan in 1989 for use in asthma and stroke. It is also being studied in the U.S. for potential treatment of amyotrophic lateral sclerosis (ALS) and drug addiction.Additionally, the SPRINT-MS study demonstrated the utility of advanced imaging in clinical trials to measure the impact of therapies on brain health. The potential application of imaging-based outcome measures may extend beyond progressive MS to other neurodegenerative disorders as well.Related StoriesScientists discover mechanism responsible for chronic inflammation in MSObesity linked with greater symptomatic severity of multiple sclerosisMice study suggests potential treatment approach for MS in humans”There is a significant need for new treatment options to effectively delay disability progression for patients with progressive MS,” said Dr. Fox. “We are hopeful these findings will help us develop more therapies for progressive MS, and do so more rapidly and efficiently.”The research, which paves the way for phase 3 testing, also determined that ibudilast is relatively safe and well tolerated. The drug has received fast-track designation from the U.S. Food & Drug Administration.”Although a larger study is needed to confirm these findings, this promising study brings people with progressive MS, who currently do not have many treatment options, one step closer to a potential therapy,” said Robin Conwit, M.D., program director at the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.The study was conducted by the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), which is sponsored by NINDS. The research was supported by NINDS, National Multiple Sclerosis Society and MediciNova.”These results are a promising step toward a potential new therapy for people living with progressive forms of MS, for whom there are few treatment options,” said Bruce Bebo, Ph.D., Executive Vice President, Research, National MS Society. “It is gratifying to see our investments in progressive MS starting to pay off.”Source: read more